MindMaze Therapeutics Holding S.A. (RLFTF) Research

MindMaze Therapeutics Holding SA, formerly known as NeuroX Group SA, is dedicated to the creation and operation of its MindMaze platform. This innovative platform integrates neuroscience and digital therapeutics to confront some of the most significant challenges in the field of neurology. The company was established in 2025 and is headquartered in Lausanne, Switzerland.

Market snapshot

Symbol
RLFTF
Price
$0.29
Day change
-13.00%
Market cap
$53.0M
P/E ratio
-3.10x
52-week range
0.272-4.88
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Arch Biopartners Inc. (ACHFF)
  • Calliditas Therapeutics Ab (CLTEF)
  • Covalon Technologies Ltd. (CVALF)
  • Helix BioPharma Corp. (HBPCF)
  • Amplia Therapeutics Limited (INNMF)
  • Oncotelic Therapeutics, Inc. (OTLC)
  • PsyBio Therapeutics Corp. (PSYBF)
  • Sernova Corp. (SEOVF)

Open MindMaze Therapeutics Holding S.A. (RLFTF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.